期刊文献+

108株耐碳青霉烯肺炎克雷伯菌的临床分布与耐药基因研究 被引量:21

Study on clinical distribution and antibiotic resistance genes of 108 isolates of carbapenem-resistant Klebsiella pneumoniae
下载PDF
导出
摘要 目的了解仁济医院耐碳青霉烯肺炎克雷伯菌株(carbapenem-resistant Klebsiella pneumoniae,CRKP)的临床分布与耐药基因型。方法收集2013年1月—2015年7月仁济医院临床分离108株CRKP,进行K-B纸片法检测18种抗菌药物敏感性、超广谱β-内酰胺酶(ESBLs)初筛及表型确证试验、聚合酶链反应检测ESBLs、碳青霉烯酶、质粒介导的AmpC酶与喹诺酮耐药基因。结果 108株CRKP对复方磺胺耐药率最低(32.4%),其次为磷霉素、庆大霉素和阿米卡星(82.4%、95.4%和97.2%)。科室分布前3位为神经外科、外科ICU和普外科。ESBLs基因中CTX-M-9,SHV和TEM酶基因阳性率为96.3%、85.2%和75.9%。108株CRKP均检测出KPC-2基因。而金属酶基因仅1株检测出IMP-1。喹诺酮耐药基因中qnrB基因检出率达91.7%(99/108)。AmpC酶中只检测出DHA基因,阳性率13.9%(15/108)。结论我院临床分离CRKP携带多种耐药基因,对数10种临床常用抗菌药物同时耐药,应加强对该类菌株的监控,控制其在院内的传播流行。 Objective To understand the clinical distribution and investigate the resistant genes carried in the clinical isolates of carbapenem-resistant Klebsiellapneumoniae (CRPK) in Renji Hospital. Methods A total of 108 carbapenem-resistant Klebsiella pneumoniae isolates were collected from January 2013 to July 2015 in Renji Hospital. Antibiotic susceptibility to 18 drugs of the isolates were determined by Kirby Bauer disk diffusion method. ESBLs- producing initial screen test and phenotypic confirmatory test were performed to detect the resistance phenotype of theisolates. Antibiotic resistance genes were investigated by PCR amplification, including ESBLs genes, carbapenemase genes, plasmid-mediated AmpC 13-1actamasegenes and quinolone resistance genes. Results 108 isolates had the lowest resistancerates to compound sulfamethoxazole (32.4%). The resistant rates to fosfomycin, gentamycin and amikacin were 82.4%, 95.4% and 97.2%, respectively. The isolates were mainly distributed in Neurosurgery, Surgical ICU and General Surgery, accounting for 18.5%, 18.5% and 15.7%, respectively. Among the ESBLs genes detected, the positive rates of CTX-M-9, SHV and TEM encoding genes were 96.3%, 85.2%, and 75.9%, respectively. KPC- 2 encoding gene was detected in all 108 isolates, while among all detected metallo-β-1actamases only IMP-1 was detected in one isolate, qnrB gene was the most frequently detected quinolone gene and its positive rate reach 91.7%(99/108). Among all investigated AmpC β-lactamasegenes only DHA was detected, of which the positive rate is 13.9 %(15/108). Conclusion The isolates of carbapenem-resistant Klebsiellapneumoniae in our hospital are resistant to various antibiotics commonly used in the clinic and carry multiple resistant genes, which has been a growing concern in the clinical treatment. It is necessary to strengthen the surveillance to prevent the further spread of the carbapenemresistant strains in the hospital.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2017年第3期218-224,共7页 Chinese Journal of Antibiotics
基金 上海市卫生局青年科研项目(No.20134Y209)
关键词 CRKP 临床分布 药敏试验 耐药基因 CRKP Clinical distribution Antimicrobial susceptibility testing Antibiotic resistance genes
  • 相关文献

参考文献3

二级参考文献36

  • 1Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
  • 3Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
  • 4Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
  • 5Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328.
  • 6Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993.
  • 7Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707.
  • 8Arnold RS,Thom KA,Sharma S,et al.Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria[J].South Med J,2011,104(1):40-45.
  • 9Borer A,Saidel-Odes L,Riesenberg K,et al.Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia[J].Infect Control Hosp Epidemiol,2009,30(10):972-976.
  • 10Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing [S].Twenty- Fourth Informational Supplement,2014,M100-S24.

共引文献852

同被引文献141

引证文献21

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部